(RXO) RXO - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US74982T1034
Stock: Truckload, Brokerage, Forwarding, Managed, Last-Mile
Total Rating 22
Risk 57
Buy Signal -0.85
| Risk 5d forecast | |
|---|---|
| Volatility | 86.7% |
| Relative Tail Risk | -9.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | -49.10 |
| Character TTM | |
|---|---|
| Beta | 1.813 |
| Beta Downside | 2.860 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.15% |
| CAGR/Max DD | -0.11 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: RXO RXO March 01, 2026
RXO, Inc. (NYSE: RXO) operates as a technology-enabled truck brokerage, offering truckload freight brokering, asset-light managed transportation, last-mile delivery, and freight-forwarding services across North America, Asia, and Europe. Incorporated in 2022 and based in Charlotte, NC, the company leverages a digital platform to match shippers with carriers while providing ancillary services such as customs brokerage and middle-mile logistics.
In its latest fiscal quarter (Q4 2025), RXO reported revenue of $1.12 billion, up 9% year-over-year, and an adjusted EBITDA margin of 12.4%, reflecting continued demand from e-commerce fulfillment and a rebound in inter-modal freight volumes. Load-to-truck ratios improved to 1.08, indicating tighter capacity utilization, while average spot truckload rates rose 4.5% YoY amid persistent driver shortages and elevated fuel prices-key macro drivers for the cargo ground transportation sector.
For a deeper quantitative view, you might explore ValueRay’s analytics on RXO.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -100.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 1.43 > 1.0 |
| NWC/Revenue: 4.86% < 20% (prev 6.02%; Δ -1.16% < -1%) |
| CFO/TA 0.02 > 3% & CFO 51.0m > Net Income -100.0m |
| Net Debt (844.0m) to EBITDA (24.0m): 35.17 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (168.7m) vs 12m ago 2.62% < -2% |
| Gross Margin: 17.15% > 18% (prev 0.16%; Δ 1699 % > 0.5%) |
| Asset Turnover: 171.6% > 50% (prev 133.3%; Δ 38.36% > 0%) |
| Interest Coverage Ratio: -2.63 > 6 (EBITDA TTM 24.0m / Interest Expense TTM 35.0m) |
Altman Z'' -0.24
| A: 0.09 (Total Current Assets 1.32b - Total Current Liabilities 1.04b) / Total Assets 3.28b |
| B: -0.12 (Retained Earnings -384.0m / Total Assets 3.28b) |
| C: -0.03 (EBIT TTM -92.0m / Avg Total Assets 3.35b) |
| D: -0.22 (Book Value of Equity -388.0m / Total Liabilities 1.74b) |
| Altman-Z'' Score: -0.24 = B |
Beneish M -3.10
| DSRI: 0.79 (Receivables 1.23b/1.23b, Revenue 5.74b/4.55b) |
| GMI: 0.96 (GM 17.15% / 16.48%) |
| AQI: 0.99 (AQ_t 0.48 / AQ_t-1 0.49) |
| SGI: 1.26 (Revenue 5.74b / 4.55b) |
| TATA: -0.05 (NI -100.0m - CFO 51.0m) / TA 3.28b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of RXO shares?
As of March 05, 2026, the stock is trading at USD 16.53 with a total of 1,524,717 shares traded.
Over the past week, the price has changed by +12.30%, over one month by -3.05%, over three months by +16.08% and over the past year by -17.80%.
Over the past week, the price has changed by +12.30%, over one month by -3.05%, over three months by +16.08% and over the past year by -17.80%.
Is RXO a buy, sell or hold?
RXO has received a consensus analysts rating of 3.10.
Therefor, it is recommend to hold RXO.
- StrongBuy: 3
- Buy: 1
- Hold: 14
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the RXO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16 | -3.2% |
| Analysts Target Price | 16 | -3.2% |
RXO Fundamental Data Overview March 05, 2026
P/E Forward = 416.6667
P/S = 0.4701
P/B = 1.7336
P/EG = 27.812
Revenue TTM = 5.74b USD
EBIT TTM = -92.0m USD
EBITDA TTM = 24.0m USD
Long Term Debt = 387.0m USD (from longTermDebt, last quarter)
Short Term Debt = 92.0m USD (from shortTermDebt, last quarter)
Debt = 861.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 844.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.54b USD (2.70b + Debt 861.0m - CCE 17.0m)
Interest Coverage Ratio = -2.63 (Ebit TTM -92.0m / Interest Expense TTM 35.0m)
EV/FCF = -442.9x (Enterprise Value 3.54b / FCF TTM -8.00m)
FCF Yield = -0.23% (FCF TTM -8.00m / Enterprise Value 3.54b)
FCF Margin = -0.14% (FCF TTM -8.00m / Revenue TTM 5.74b)
Net Margin = -1.74% (Net Income TTM -100.0m / Revenue TTM 5.74b)
Gross Margin = 17.15% ((Revenue TTM 5.74b - Cost of Revenue TTM 4.76b) / Revenue TTM)
Gross Margin QoQ = 19.95% (prev 16.61%)
Tobins Q-Ratio = 1.08 (Enterprise Value 3.54b / Total Assets 3.28b)
Interest Expense / Debt = 1.05% (Interest Expense 9.00m / Debt 861.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -72.7m (EBIT -92.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.27 (Total Current Assets 1.32b / Total Current Liabilities 1.04b)
Debt / Equity = 0.56 (Debt 861.0m / totalStockholderEquity, last quarter 1.54b)
Debt / EBITDA = 35.17 (Net Debt 844.0m / EBITDA 24.0m)
Debt / FCF = -105.5 (out of range, set to none) (Net Debt 844.0m / FCF TTM -8.00m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.99% (Net Income -100.0m / Total Assets 3.28b)
RoE = -6.35% (Net Income TTM -100.0m / Total Stockholder Equity 1.57b)
RoCE = -4.69% (EBIT -92.0m / Capital Employed (Equity 1.57b + L.T.Debt 387.0m))
RoIC = -3.68% (negative operating profit) (NOPAT -72.7m / Invested Capital 1.98b)
WACC = 9.75% (E(2.70b)/V(3.56b) * Re(12.60%) + D(861.0m)/V(3.56b) * Rd(1.05%) * (1-Tc(0.21)))
Discount Rate = 12.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.78%
[DCF] Fair Price = unknown (Cash Flow -8.00m)
EPS Correlation: -43.68 | EPS CAGR: -9.04% | SUE: -0.22 | # QB: 0
Revenue Correlation: 42.64 | Revenue CAGR: 3.06% | SUE: -0.58 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.02 | Chg7d=+0.000 | Chg30d=-0.029 | Revisions Net=-9 | Analysts=17
EPS current Year (2026-12-31): EPS=0.00 | Chg7d=+0.000 | Chg30d=-0.100 | Revisions Net=-15 | Growth EPS=+111.1% | Growth Revenue=+0.9%
EPS next Year (2027-12-31): EPS=0.40 | Chg7d=+0.000 | Chg30d=-0.062 | Revisions Net=-10 | Growth EPS=+8822.2% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 9 Down within 30d for Next Quarter)
P/S = 0.4701
P/B = 1.7336
P/EG = 27.812
Revenue TTM = 5.74b USD
EBIT TTM = -92.0m USD
EBITDA TTM = 24.0m USD
Long Term Debt = 387.0m USD (from longTermDebt, last quarter)
Short Term Debt = 92.0m USD (from shortTermDebt, last quarter)
Debt = 861.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 844.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.54b USD (2.70b + Debt 861.0m - CCE 17.0m)
Interest Coverage Ratio = -2.63 (Ebit TTM -92.0m / Interest Expense TTM 35.0m)
EV/FCF = -442.9x (Enterprise Value 3.54b / FCF TTM -8.00m)
FCF Yield = -0.23% (FCF TTM -8.00m / Enterprise Value 3.54b)
FCF Margin = -0.14% (FCF TTM -8.00m / Revenue TTM 5.74b)
Net Margin = -1.74% (Net Income TTM -100.0m / Revenue TTM 5.74b)
Gross Margin = 17.15% ((Revenue TTM 5.74b - Cost of Revenue TTM 4.76b) / Revenue TTM)
Gross Margin QoQ = 19.95% (prev 16.61%)
Tobins Q-Ratio = 1.08 (Enterprise Value 3.54b / Total Assets 3.28b)
Interest Expense / Debt = 1.05% (Interest Expense 9.00m / Debt 861.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -72.7m (EBIT -92.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.27 (Total Current Assets 1.32b / Total Current Liabilities 1.04b)
Debt / Equity = 0.56 (Debt 861.0m / totalStockholderEquity, last quarter 1.54b)
Debt / EBITDA = 35.17 (Net Debt 844.0m / EBITDA 24.0m)
Debt / FCF = -105.5 (out of range, set to none) (Net Debt 844.0m / FCF TTM -8.00m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.99% (Net Income -100.0m / Total Assets 3.28b)
RoE = -6.35% (Net Income TTM -100.0m / Total Stockholder Equity 1.57b)
RoCE = -4.69% (EBIT -92.0m / Capital Employed (Equity 1.57b + L.T.Debt 387.0m))
RoIC = -3.68% (negative operating profit) (NOPAT -72.7m / Invested Capital 1.98b)
WACC = 9.75% (E(2.70b)/V(3.56b) * Re(12.60%) + D(861.0m)/V(3.56b) * Rd(1.05%) * (1-Tc(0.21)))
Discount Rate = 12.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.78%
[DCF] Fair Price = unknown (Cash Flow -8.00m)
EPS Correlation: -43.68 | EPS CAGR: -9.04% | SUE: -0.22 | # QB: 0
Revenue Correlation: 42.64 | Revenue CAGR: 3.06% | SUE: -0.58 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.02 | Chg7d=+0.000 | Chg30d=-0.029 | Revisions Net=-9 | Analysts=17
EPS current Year (2026-12-31): EPS=0.00 | Chg7d=+0.000 | Chg30d=-0.100 | Revisions Net=-15 | Growth EPS=+111.1% | Growth Revenue=+0.9%
EPS next Year (2027-12-31): EPS=0.40 | Chg7d=+0.000 | Chg30d=-0.062 | Revisions Net=-10 | Growth EPS=+8822.2% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 9 Down within 30d for Next Quarter)